Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Palmer

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Journal of Virology|November 27, 2004
In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaquesZandrea Ambrose, Valerie Boltz, Sarah Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excisionGalina N Nikolenko, Sarah Palmer, Frank Maldarelli, et al.
AIDS (London, England)|December 6, 2012
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllersViktor Dahl, Julia Peterson, Serena Spudich, et al.
The Journal of Infectious Diseases|December 17, 2013
An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapyViktor Dahl, Magnus Gisslen, Lars Hagberg, et al.
Protein Expression and Purification|March 26, 2003
HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallizationJohn F Vickrey, Bradley C Logsdon, Gheorghe Proteasa, et al.
Clinical Trials (London, England)|March 15, 2019
Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB RelianceOrly Vardeny, Adrian F Hernandez, Lauren W Cohen, et al.
Surgical Innovation|August 23, 2019
Substitution of Transcatheter for Surgical Aortic Valve Replacement: An Observational StudySarah Palmer, Devraj Sukul, Nicholas M Moloci, et al.
Nature Structural & Molecular Biology|April 21, 2004
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genomeQin Yu, Renate König, Satish Pillai, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistanceGalina N Nikolenko, Krista A Delviks-Frankenberry, Sarah Palmer, et al.
The Journal of Infectious Diseases|October 25, 2011
Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapyViktor Dahl, Evelyn Lee, Julia Peterson, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Journal of Virology|November 27, 2004
In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaquesZandrea Ambrose, Valerie Boltz, Sarah Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excisionGalina N Nikolenko, Sarah Palmer, Frank Maldarelli, et al.
AIDS (London, England)|December 6, 2012
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllersViktor Dahl, Julia Peterson, Serena Spudich, et al.
The Journal of Infectious Diseases|December 17, 2013
An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapyViktor Dahl, Magnus Gisslen, Lars Hagberg, et al.
Protein Expression and Purification|March 26, 2003
HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallizationJohn F Vickrey, Bradley C Logsdon, Gheorghe Proteasa, et al.
Clinical Trials (London, England)|March 15, 2019
Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB RelianceOrly Vardeny, Adrian F Hernandez, Lauren W Cohen, et al.
Surgical Innovation|August 23, 2019
Substitution of Transcatheter for Surgical Aortic Valve Replacement: An Observational StudySarah Palmer, Devraj Sukul, Nicholas M Moloci, et al.
Nature Structural & Molecular Biology|April 21, 2004
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genomeQin Yu, Renate König, Satish Pillai, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistanceGalina N Nikolenko, Krista A Delviks-Frankenberry, Sarah Palmer, et al.
The Journal of Infectious Diseases|October 25, 2011
Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapyViktor Dahl, Evelyn Lee, Julia Peterson, et al.
Pageof 14